155 related articles for article (PubMed ID: 32546255)
1. Hepatitis in children with tuberculosis: a case report and review of the literature.
Sanchez-Codez M; Hunt WG; Watson J; Mejias A
BMC Pulm Med; 2020 Jun; 20(1):173. PubMed ID: 32546255
[TBL] [Abstract][Full Text] [Related]
2. [Fulminant hepatitis in the course of antitubercular treatment (apropos of 2 cases)].
Mbaye PS; Talarmin F; Sane M; Eladari D; Klotz F
Dakar Med; 1995; 40(2):129-31. PubMed ID: 9827070
[TBL] [Abstract][Full Text] [Related]
3. Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment.
Chen L; Bao D; Gu L; Gu Y; Zhou L; Gao Z; Huang Y
BMC Infect Dis; 2018 Jul; 18(1):295. PubMed ID: 29970037
[TBL] [Abstract][Full Text] [Related]
4. Antituberculosis drug-induced hepatotoxicity is uncommon in Tanzanian hospitalized pulmonary TB patients.
Tostmann A; van den Boogaard J; Semvua H; Kisonga R; Kibiki GS; Aarnoutse RE; Boeree MJ
Trop Med Int Health; 2010 Feb; 15(2):268-72. PubMed ID: 20409289
[TBL] [Abstract][Full Text] [Related]
5. Effect of anti-tuberculosis therapy on liver function of pulmonary tuberculosis patients infected with hepatitis B virus.
Pan L; Jia ZS; Chen L; Fu EQ; Li GY
World J Gastroenterol; 2005 Apr; 11(16):2518-21. PubMed ID: 15832429
[TBL] [Abstract][Full Text] [Related]
6. Immune Reconstitution Inflammatory Syndrome and Drug-Induced Liver Injury During Treatment of Disseminated Tuberculosis in a Liver Transplant Recipient: A Case Report.
Lee S; Yi NJ; Kwak N; Kim H; Hong SY; Lee JM; Hong SK; Choi Y; Lee KW; Suh KS
Transplant Proc; 2023 Oct; 55(8):1972-1974. PubMed ID: 37468353
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus infection: a challenge in the complex management of two cases of multidrug-resistant tuberculosis.
Musso M; Mosti S; Gualano G; Mencarini P; Urso R; Ghirga P; Rianda A; Del Nonno F; Goletti D; Palmieri F
BMC Infect Dis; 2019 Oct; 19(1):882. PubMed ID: 31640579
[TBL] [Abstract][Full Text] [Related]
8. Antituberculosis Drug-induced Liver Injury in Children: Incidence and Risk Factors During the Two-month Intensive Phase of Therapy.
Gafar F; Arifin H; Jurnalis YD; Yani FF; Fitria N; Alffenaar JC; Wilffert B
Pediatr Infect Dis J; 2019 Jan; 38(1):50-53. PubMed ID: 30234790
[TBL] [Abstract][Full Text] [Related]
9. Ofloxacin in miliary tuberculosis.
Alegre J; Fernández de Sevilla T; Falcó V; Martinez Vazquez JM
Eur Respir J; 1990 Feb; 3(2):238-9. PubMed ID: 2311746
[TBL] [Abstract][Full Text] [Related]
10. The clinical impact of drug-induced hepatotoxicity on anti-tuberculosis therapy: a case control study.
Song JH; Yoon SY; Park TY; Heo EY; Kim DK; Chung HS; Lee JK
Respir Res; 2019 Dec; 20(1):283. PubMed ID: 31842883
[TBL] [Abstract][Full Text] [Related]
11. Incidence, clinical and epidemiological risk factors, and outcome of drug-induced hepatitis due to antituberculous agents in new tuberculosis cases.
Baghaei P; Tabarsi P; Chitsaz E; Saleh M; Marjani M; Shemirani S; Pooramiri MV; Kazempour M; Farnia P; Fahimi F; Mansouri D; Masjedi M
Am J Ther; 2010; 17(1):17-22. PubMed ID: 19535968
[TBL] [Abstract][Full Text] [Related]
12. Isoniazid- and streptomycin-resistant miliary tuberculosis complicated by intracranial tuberculoma in a Japanese infant.
Ishiwada N; Tokunaga O; Nagasawa K; Ichimoto K; Kinoshita K; Hishiki H; Kohno Y
Tohoku J Exp Med; 2013 Mar; 229(3):221-5. PubMed ID: 23470647
[TBL] [Abstract][Full Text] [Related]
13. Revised Antituberculosis Drug Doses and Hepatotoxicity in HIV Negative Children.
Indumathi CK; Sethuraman A; Jain S; Krishnamurthy S
Indian J Pediatr; 2019 Mar; 86(3):229-232. PubMed ID: 30515702
[TBL] [Abstract][Full Text] [Related]
14. Empirical treatment of tuberculosis: TB or not TB?
Webb E; Kali Vanan N; Biswas R
BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 29991543
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients.
Teixeira RL; Morato RG; Cabello PH; Muniz LM; Moreira Ada S; Kritski AL; Mello FC; Suffys PN; Miranda AB; Santos AR
Mem Inst Oswaldo Cruz; 2011 Sep; 106(6):716-24. PubMed ID: 22012226
[TBL] [Abstract][Full Text] [Related]
16. Short-course therapy for tuberculosis in infants and children. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
CMAJ; 1994 Apr; 150(8):1233-9. PubMed ID: 8162546
[TBL] [Abstract][Full Text] [Related]
17. Management of antitubercular drugs-induced hepatotoxicity and therapy reintroduction strategy in a TB clinic of Nepal.
Shakya R; Rao BS; Shrestha B
Kathmandu Univ Med J (KUMJ); 2005; 3(1):45-9. PubMed ID: 16401944
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Risk Factors for Development of Anti-Tubercular Therapy Induced Hepatotoxicity: A Prospective Study.
Subbalaxmi MVS; Soanker R; Lakshmi AV
Curr Drug Saf; 2020; 15(3):198-204. PubMed ID: 32589563
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Hepatotoxicity From Antituberculosis Therapy: A Five-Year Experience From South India.
Saha A; Shanthi F X M; Winston A B; Das S; Kumar A; Michael JS; Balamugesh T
J Prim Care Community Health; 2016 Jul; 7(3):171-4. PubMed ID: 27056794
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced hepatotoxicity of anti-tuberculosis drugs and their serum levels.
Jeong I; Park JS; Cho YJ; Yoon HI; Song J; Lee CT; Lee JH
J Korean Med Sci; 2015 Feb; 30(2):167-72. PubMed ID: 25653488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
